Search results for "Epidemiology"

showing 10 items of 4214 documents

Early life body mass trajectories and mortality in older age: Findings from the Helsinki Birth Cohort Study

2014

Overweight and obesity in childhood have been linked to an increased risk of adult mortality, but evidence is still scarce.We identified trajectories of body mass index (BMI) development in early life and investigated their mortality risk. Data come from the Helsinki Birth Cohort Study, in which 4943 individuals, born 1934-1944, had serial measures of weight and height from birth to 11 years extracted from health care records, weight and height data in adulthood, and register-based mortality data for 2000-2010.Three early BMI trajectories (increasing, average, and average-to-low for men and increasing, average, and low-to-high BMI for women) were identified. Women with an increasing or low-…

AdultMaleRiskPediatricsmedicine.medical_specialtyAgingDatabases Factualbody mass indexOverweightChildhood obesityImpaired glucose toleranceCohort StudiesBreast cancerCause of DeathNeoplasmsmedicineHumansEarly childhoodChildFinlandAgedbusiness.industryBody WeightAge FactorsInfant NewbornBayes Theoremta3141General MedicineMiddle AgedOverweightgrowth mixture modelsmedicine.diseaseObesitymortalitydevelopmental origins of adult health and diseaseChild PreschoolFemalelife-course epidemiologymedicine.symptomBirth cohortbusinessBody mass indexbirth sizeAnnals of Medicine
researchProduct

Omalizumab and the risk of malignancy: results from a pooled analysis.

2011

Background Since initial registration, the omalizumab clinical trial database has expanded considerably, with a doubling of patients exposed in the clinical trial environment. Previous pooled data (2003) from phase I to III studies of omalizumab showed a numeric imbalance in malignancies arising in omalizumab recipients (0.5%) compared with control subjects (0.2%). The previous analysis was based on limited available data, warranting further investigation. Objective We sought to examine the incidence of malignancy using comprehensive pooled data from clinical trials of omalizumab-treated patients. Methods This pooled analysis included data from 67 phase I to IV clinical trials. The prespeci…

AdultMaleRiskmedicine.medical_specialtyAdolescentImmunologyOmalizumabOmalizumabRate ratioMalignancyAntibodies Monoclonal HumanizedYoung AdultInternal medicineNeoplasmsImmunology and AllergyMedicineHumansAnti-Asthmatic AgentsYoung adultAdverse effectChildAsthmaAgedAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceAntibodies MonoclonalMiddle Agedmedicine.diseaseSurgeryAntibodies Anti-IdiotypicClinical trialChild PreschoolFemalebusinessmedicine.drugThe Journal of allergy and clinical immunology
researchProduct

Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary he…

2009

Despite the consistent association between cholesteryl ester transfer protein (CETP) gene variation and plasma HDL-C, huge controversy still rages on its association with coronary heart disease (CHD). We investigated the association between the CETP-TaqIB polymorphism, HDL-C and incident CHD in a Mediterranean population.A nested case-control study among participants of the Spanish EPIC cohort was performed. 41,440 healthy individuals (30-69 years) were followed up over a 10-year period, incident CHD cases being identified. We analyzed 557 confirmed CHD cases and 1180 healthy controls.Despite B2B2 subjects having the highest HDL-C concentrations and B1B1, the lowest (P0.001), no protective …

AdultMaleRiskmedicine.medical_specialtyAlcohol DrinkingPopulationCoronary DiseaseGastroenterologychemistry.chemical_compoundHigh-density lipoproteinInternal medicineDiabetes mellitusCholesterylester transfer proteinEpidemiologymedicineHumanseducationAgededucation.field_of_studyPolymorphism Geneticbiologybusiness.industryCholesterolMediterranean RegionIncidence (epidemiology)Cholesterol HDLGenetic VariationMiddle Agedmedicine.diseaseCholesterol Ester Transfer ProteinsEndocrinologychemistryCase-Control StudiesCohortbiology.proteinlipids (amino acids peptides and proteins)FemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesAtherosclerosis
researchProduct

Thirty-one novel biomarkers as predictors for clinically incident diabetes.

2010

Background The prevalence of diabetes is increasing in all industrialized countries and its prevention has become a public health priority. However, the predictors of diabetes risk are insufficiently understood. We evaluated, whether 31 novel biomarkers could help to predict the risk of incident diabetes. Methods and Findings The biomarkers were evaluated primarily in the FINRISK97 cohort (n = 7,827; 417 cases of clinically incident diabetes during the follow-up). The findings were replicated in the Health 2000 cohort (n = 4,977; 179 cases of clinically incident diabetes during the follow-up). We used Cox proportional hazards models to calculate the relative risk of diabetes, after adjustin…

AdultMaleRiskmedicine.medical_specialtyDiabetes riskPublic Health and Epidemiologylcsh:Medicine030209 endocrinology & metabolism030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineSex FactorsPredictive Value of TestsDiabetes mellitusInternal medicinemedicineDiabetes MellitusHumansCardiovascular Disorders/Vascular Biologylcsh:ScienceAgedApolipoproteins BProportional Hazards ModelsMultidisciplinaryAdiponectinbiologyProportional hazards modelbusiness.industrylcsh:RC-reactive proteinMiddle Agedmedicine.disease3. Good healthDiabetes and EndocrinologyC-Reactive ProteinROC CurveRelative riskImmunologyCohortFerritinsbiology.proteinlcsh:QFemaleAdiponectinbusinessBiomarkersCohort studyResearch ArticlePloS one
researchProduct

Leisure-time cross-country skiing and risk of atrial fibrillation and stroke:a prospective cohort study

2020

[No Abstract]

AdultMaleRiskmedicine.medical_specialtyEpidemiologyLeisure timeMEDLINEaivohalvausLeisure ActivitiesSkiingAtrial FibrillationmedicineHumansatrial fibrillationProspective StudiesProspective cohort studyStrokeFinlandCross countrybusiness.industryAtrial fibrillationleisure-timeMiddle Agedmedicine.diseaseeteisvärinähiihtostrokeStrokeEmergency medicineCardiology and Cardiovascular Medicinebusinesscross-country skiingvapaa-aika
researchProduct

Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk:An International …

2017

Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99. mm. Hg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular mortality ≥1% and <5% at 10 years) absolute total cardiovascular risk (CVR) should be treated with antihypertensive agents. A virtual international consultation process was undertaken to summarize the opinions of select experts. After holistic analysis of all epidemiological, clinical, psychosocial, and public health elements, this consultation process reached the following consensus in hypertensive adults aged <80 years: (1) The question of whether drug treat…

AdultMaleRiskmedicine.medical_specialtyPediatricsEvidence-based practiceHeart Diseasesmedicine.drug_classMEDLINE030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineHypertension/complicationsEpidemiologymedicineHumans030212 general & internal medicineRisk factorAntihypertensive drugAntihypertensive AgentsDisease burdenAntihypertensive Agents/therapeutic usebusiness.industryPublic healthHeart Diseases/etiologyGeneral MedicineHypertensionFemaleCardiology and Cardiovascular MedicinebusinessPsychosocial
researchProduct

A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK Project.

2020

AbstractThis study aimed to assess atrial fibrillation (AF) incidence and predictive factors in hypertensive patients and to formulate an AF risk assessment score that can be used to identify the patients most likely to develop AF. This was a cohort study of patients recruited in primary healthcare centers. Patients aged 40 years or older with hypertension, free of AF and with no previous cardiovascular events were included. Patients attended annual visits according to clinical practice until the end of study or onset of AF. The association between AF incidence and explanatory variables (age, sex, body mass index, medical history and other) was analyzed. Finally, 12,206 patients were includ…

AdultMaleRiskmedicine.medical_specialtyTime FactorsCardiologylcsh:Medicine030204 cardiovascular system & hematologyRisk AssessmentArticleCohort Studies03 medical and health sciencesSex Factors0302 clinical medicineInternal medicineAtrial FibrillationmedicineHumansObesity030212 general & internal medicinelcsh:ScienceAgedHeart FailureMultidisciplinaryFramingham Risk Scorebusiness.industryIncidenceIncidence (epidemiology)lcsh:RHazard ratioAge FactorsAtrial fibrillationMiddle Agedmedicine.diseaseConfidence intervalRisk factorsResearch DesignHypertensionFemalelcsh:QbusinessRisk assessmentBody mass indexFollow-Up StudiesForecastingCohort study
researchProduct

Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis

2015

Background: Although vitamin K antagonists (VKAs) lower serum values of bone deposition markers, the link with osteoporosis and fractures remains controversial. Objectives: To assess whether the use of VKAs is associated with an increased prevalence and/or incidence of osteoporosis, fractures, or lower bone mineral density (BMD) values. Methods: We conducted a systematic PubMed and EMBASE literature search until August 31, 2014, and a meta-analysis of cross-sectional and longitudinal studies investigating fractures and BMD, comparing patients treated with VKAs and healthy controls (HCs) or with patients with medical illness (medical controls, MCs). Standardized mean differences ± 95% and co…

AdultMaleRiskmedicine.medical_specialtyVitamin KBone mineral density; Coumadin; Fractures bone; Hip fractures; Osteoporosis; HematologyOsteoporosisbonefractures boneSex FactorsBone DensityInternal medicinemedicineHumansLongitudinal StudiesAgedBone mineralHip fracturebusiness.industryIncidenceIncidence (epidemiology)ConfoundingAge FactorsAnticoagulantsConfounding Factors EpidemiologicHematologyMiddle Agedmedicine.diseaseosteoporosisConfidence intervalSurgeryObservational Studies as TopicCross-Sectional StudiesFractures Spontaneouship fractureMeta-analysisRelative riskHip fracturescoumadinFemalebone mineral densitybusinessFracturesJournal of Thrombosis and Haemostasis
researchProduct

The HLA locus and multiple sclerosis in Sicily

2005

The authors report the analysis of HLA-class II allelic heterogeneity in a well characterized multiple sclerosis (MS) Sicilian dataset. Family-based association analysis revealed evidence for excess transmission to affected individuals for alleles HLA-DRB1*1501, DRB1*04, and DQB1*0302. When analyzed as haplotypes, the authors observed excess transmission for the DRB1*0400-DQB1*0302 haplotype. Sicilian patients share the HLA-DRB1*1501 susceptibility allele with affecteds living in continental Italy, but also display the allelic heterogeneity that characterizes Mediterranean populations.

AdultMaleRiskmusculoskeletal diseasesMultiple SclerosisAdolescentGenes MHC Class IILocus (genetics)Human leukocyte antigenBiologySeverity of Illness IndexLinkage DisequilibriumCohort StudiesDisability EvaluationGene Frequencyimmune system diseasesMultiple Sclerosis/epidemiologyPrevalencemedicineHumansGenetic Predisposition to DiseaseAge of OnsetAlleleskin and connective tissue diseasesSicilyAllelesGenetic associationGeneticsHLA-D AntigensIncidenceMultiple sclerosisHaplotypeGene Poolmedicine.diseaselanguage.human_languageSettore BIO/18 - GeneticaHaplotypeslanguageFemaleAllelic heterogeneitySettore MED/26 - NeurologiaNeurology (clinical)Sicilian
researchProduct

Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance net…

2011

SUMMARYEuroRotaNet, a laboratory network, was established in order to determine the diversity of co-circulating rotavirus strains in Europe over three or more rotavirus seasons from 2006/2007 and currently includes 16 countries. This report highlights the tremendous diversity of rotavirus strains co-circulating in the European population during three years of surveillance since 2006/2007 and points to the possible origins of these strains including genetic reassortment and interspecies transmission. Furthermore, the ability of the network to identify strains circulating with an incidence of ⩾1% allowed the identification of possible emerging strains such as G8 and G12 since the beginning of…

AdultMaleRotavirusAdolescentGenotypeEpidemiologyInternational CooperationReassortmentReoviridaemedicine.disease_causeRotavirus InfectionsYoung Adult03 medical and health sciencesSex FactorsPan european[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRotavirusGenotypemedicineHumansChildAged030304 developmental biologyAged 80 and overMolecular Epidemiology0303 health sciencesMolecular epidemiologybiology030306 microbiologyStrain (biology)Incidence (epidemiology)Age FactorsRotavirus VaccinesInfantMiddle Agedbiology.organism_classificationVirology3. Good healthEuropeInfectious DiseasesChild PreschoolPopulation Surveillance[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemaleSeasonsEpidemiology and Infection
researchProduct